相关实验视频
Updated: Jul 26, 2026

08:39
Operant Sensation Seeking in the Mouse
Published on: November 10, 2010
13.4K
在基因多样化的小鼠群体中,静脉可卡因自我管理的多个阶段的行为变化
Price E Dickson1,2,3, Udita Datta1,2, Troy D Wilcox1,2
1Mammalian Genetics, The Jackson Laboratory, Bar Harbor, ME, USA.
Psychopharmacology
|September 15, 2025
概括
高多样性的小鼠模型揭示了对可卡因成进展的遗传影响. 在不同小鼠种群中使用可卡因自我管理的研究发现了物质使用行为中的显著菌株和性别差异.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 遗传因素显著影响从最初的药物使用到强迫性物质使用的过渡.
- 在小鼠中,操作性可卡因的自我管理是研究成生物学的一个关键模型.
- 现有的研究往往缺乏遗传多样性,只关注自我管理的早期阶段.
研究的目的:
- 在基因多样化的小鼠群体中,在可卡因自我管理的多个阶段中描述行为表型.
- 调查遗传背景和性别对可卡因摄入量和相关行为的影响.
- 确定极端遗传模型来研究物质使用障碍的生物机制.
主要方法:
- 利用了三个高度多样化的小鼠种群:协作交叉 (CC) 菌株,多样性异种 (J:DO) 鼠标和创始菌株.
- 雇员扩展可卡因静脉自给药 (IVSA) 协议,涵盖获得,剂量反应,灭绝和恢复.
- 分析了对菌株和性别差异的行为数据,计算了遗传概率估计.
主要成果:
- 在可卡因自我管理的所有阶段观察到明显的菌株特异性差异.
- 对自我管理行为的遗传概率估计范围从0到0.585.5.
- 在各种行为指标中确定了大量的性别差异和性别相互作用.
- CC和J:DO小鼠表现出表型值,通常超过创始菌株中观察到的范围,包括C57BL/6J.
结论:
- 在高多样性的小鼠群体中,扩展的自我管理协议有效地揭示了复杂的行为表型.
- 这些模型对于发现和描述物质使用特征的生物学基础是有价值的.
- 高多样性的小鼠种群为成和强迫行为临床前研究提供了强大的工具.
相关概念视频
Multiple Allele Traits
The Concept of Multiple Allelism
Alterations in Blood Pressure
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Neural Regulation of Blood Pressure
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

